Published in BMC Immunol on March 08, 2011
The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis. Ann N Y Acad Sci (2013) 1.30
Antihyperglycemic Potential of Grewia asiatica Fruit Extract against Streptozotocin-Induced Hyperglycemia in Rats: Anti-Inflammatory and Antioxidant Mechanisms. Oxid Med Cell Longev (2015) 0.80
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes (1999) 5.96
Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol (1994) 5.66
Use of staphylococcal protein A as an immunological reagent. J Immunol Methods (1978) 5.19
Quantification and significance of protein oxidation in biological samples. Drug Metab Rev (2001) 2.21
RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. J Am Soc Nephrol (2009) 1.72
Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes (2002) 1.67
Advanced glycation end-products and the progress of diabetic vascular complications. Physiol Res (2004) 1.40
Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia (1995) 1.31
Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold. Kidney Int (2001) 1.26
Recombinant Fabs of human monoclonal antibodies specific to the middle epitope of GAD65 inhibit type 1 diabetes-specific GAD65Abs. Diabetes (2003) 1.23
GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes (1994) 1.22
Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes (1994) 1.13
COOH-terminal clustering of autoantibody and T-cell determinants on the structure of GAD65 provide insights into the molecular basis of autoreactivity. Diabetes (2008) 1.11
Immunization of mice with human 60-kd Ro peptides results in epitope spreading if the peptides are highly homologous between human and mouse. Arthritis Rheum (1999) 1.11
Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes. J Clin Endocrinol Metab (2000) 1.06
Modulation of antigen presentation by autoreactive B cell clones specific for GAD65 from a type I diabetic patient. Clin Exp Immunol (2004) 0.99
Epitope spreading and a varying but not disease-specific GAD65 antibody response in Type I diabetes. The Childhood Diabetes in Finland Study Group. Diabetologia (2000) 0.96
Multiplicity of the antibody response to GAD65 in Type I diabetes. Clin Exp Immunol (2004) 0.92
Characterization of hydroxyl radical modified GAD65: a potential autoantigen in type 1 diabetes. Autoimmunity (2009) 0.85
Glutamate decarboxylase (GAD) autoantibody epitope shift during the first year of type 1 diabetes. Horm Metab Res (1999) 0.80
Enhanced binding of circulating SLE autoantibodies to catecholestrogen-copper-modified DNA. Mol Cell Biochem (2008) 0.79
Controversies on humoral immune markers of insulin-dependent diabetes mellitus. J Pediatr Endocrinol Metab (1998) 0.77
Biochemical, biophysical, and thermodynamic analysis of in vitro glycated human serum albumin. Biochemistry (Mosc) (2007) 0.89
Antibodies against gluco-oxidatively modified human serum albumin detected in diabetes-associated complications. Int Arch Allergy Immunol (2010) 0.86